NervGen Pharma switches auditor to KPMG US from KPMG Canada
NGEN•NervGen Pharma will replace KPMG Canada with KPMG US as its auditor effective Sept. 15, 2026. The company said KPMG Canada resigned at its request and reported no modified audit opinions or reportable events tied to the past two completed financial years through that date.
1. Auditor change
NervGen Pharma will replace KPMG Canada with KPMG US as its auditor effective Sept. 15, 2026. KPMG Canada resigned at the company’s request. The company said there were no modified audit opinions for the past two completed financial years and management reported no reportable events tied to those audits through the effective date.
